1. Home
  2. BRX vs RGEN Comparison

BRX vs RGEN Comparison

Compare BRX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRX
  • RGEN
  • Stock Information
  • Founded
  • BRX 2011
  • RGEN 1981
  • Country
  • BRX United States
  • RGEN United States
  • Employees
  • BRX N/A
  • RGEN N/A
  • Industry
  • BRX Real Estate Investment Trusts
  • RGEN Medical/Dental Instruments
  • Sector
  • BRX Real Estate
  • RGEN Health Care
  • Exchange
  • BRX Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • BRX 8.0B
  • RGEN 8.0B
  • IPO Year
  • BRX 2013
  • RGEN N/A
  • Fundamental
  • Price
  • BRX $26.15
  • RGEN $123.26
  • Analyst Decision
  • BRX Buy
  • RGEN Buy
  • Analyst Count
  • BRX 13
  • RGEN 12
  • Target Price
  • BRX $30.40
  • RGEN $172.67
  • AVG Volume (30 Days)
  • BRX 2.2M
  • RGEN 793.9K
  • Earning Date
  • BRX 04-28-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • BRX 4.40%
  • RGEN N/A
  • EPS Growth
  • BRX 12.84
  • RGEN N/A
  • EPS
  • BRX 1.05
  • RGEN N/A
  • Revenue
  • BRX $1,302,325,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • BRX $5.60
  • RGEN $13.93
  • Revenue Next Year
  • BRX $4.35
  • RGEN $14.35
  • P/E Ratio
  • BRX $24.90
  • RGEN N/A
  • Revenue Growth
  • BRX 3.87
  • RGEN 4.88
  • 52 Week Low
  • BRX $21.32
  • RGEN $102.97
  • 52 Week High
  • BRX $30.67
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • BRX 56.03
  • RGEN 41.34
  • Support Level
  • BRX $25.39
  • RGEN $123.10
  • Resistance Level
  • BRX $26.49
  • RGEN $135.47
  • Average True Range (ATR)
  • BRX 0.58
  • RGEN 7.10
  • MACD
  • BRX 0.11
  • RGEN -1.05
  • Stochastic Oscillator
  • BRX 84.91
  • RGEN 5.39

About BRX Brixmor Property Group Inc.

Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: